New Analysis of Rekovelle Data Further Supports Use of AMH to Personali
Rekovelle’s unique dosing algorithm, which is based on a woman’s anti-Mül...
2018-07-06
文传商讯
Merck and Pfizer Advance Clinical Development Program with Two Addition
Initiation of Phase III JAVELIN Ovarian 200 trial investigating avelumab as ...
2016-01-07
文传商讯
Merck, Pfizer and Syndax Announce Collaboration to Evaluate Combination
• Merck, Pfizer and Syndax will collaborate to investigate safety, tole...
2016-01-07
文传商讯
